Garrison Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $2.02M | Sell |
2,276
-301
| -12% | -$271K | 1.02% | 42 |
|
|
2024
Q2 | $2.33M | Sell |
2,577
-120
| -4% | -$96K | 1.23% | 32 |
|
|
2024
Q1 | $2.1M | Hold |
2,697
| – | – | 1.1% | 37 |
|
|
2023
Q4 | $1.57M | Sell |
2,697
-92
| -3% | -$53.7K | 0.87% | 45 |
|
|
2023
Q3 | $1.5M | Buy |
2,789
+66
| +2% | +$34K | 0.91% | 42 |
|
|
2023
Q2 | $1.28M | Sell |
2,723
-106
| -4% | -$44.5K | 0.77% | 45 |
|
|
2023
Q1 | $972K | Sell |
2,829
-90
| -3% | -$30.4K | 0.6% | 48 |
|
|
2022
Q4 | $1.07M | Sell |
2,919
-18
| -0.6% | -$6.38K | 0.69% | 47 |
|
|
2022
Q3 | $950K | Sell |
2,937
-60
| -2% | -$19K | 0.67% | 49 |
|
|
2022
Q2 | $972K | Sell |
2,997
-160
| -5% | -$48K | 0.65% | 49 |
|
|
2022
Q1 | $904K | Sell |
3,157
-23
| -0.7% | -$5.92K | 0.51% | 53 |
|
|
2021
Q4 | $878K | Sell |
3,180
-67
| -2% | -$17K | 0.48% | 52 |
|
|
2021
Q3 | $750K | Sell |
3,247
-21
| -0.6% | -$5.18K | 0.46% | 53 |
|
|
2021
Q2 | $750K | Sell |
3,268
-46
| -1% | -$9.24K | 0.45% | 53 |
|
|
2021
Q1 | $619K | Buy |
3,314
+16
| +0.5% | +$3.13K | 0.39% | 56 |
|
|
2020
Q4 | $557K | Sell |
3,298
-2,848
| -46% | -$425K | 0.38% | 52 |
|
|
2020
Q3 | $910K | Sell |
6,146
-75
| -1% | -$11.6K | 0.48% | 49 |
|
|
2020
Q2 | $1.02M | Sell |
6,221
-200
| -3% | -$30.7K | 0.57% | 47 |
|
|
2020
Q1 | $891K | Sell |
6,421
-117
| -2% | -$16.1K | 0.6% | 46 |
|
|
2019
Q4 | $859K | Sell |
6,538
-40
| -0.6% | -$4.64K | 0.42% | 51 |
|
|
2019
Q3 | $736K | Sell |
6,578
-68
| -1% | -$7.57K | 0.38% | 55 |
|
|
2019
Q2 | $736K | Sell |
6,646
-64
| -1% | -$7.54K | 0.38% | 53 |
|
|
2019
Q1 | $871K | Sell |
6,710
-74
| -1% | -$9K | 0.46% | 52 |
|
|
2018
Q4 | $785K | Sell |
6,784
-719
| -10% | -$80.3K | 0.46% | 51 |
|
|
2018
Q3 | $805K | Sell |
7,503
-639
| -8% | -$63.9K | 0.4% | 54 |
|
|
2018
Q2 | $695K | Buy |
8,142
+121
| +2% | +$9.94K | 0.35% | 58 |
|
|
2018
Q1 | $621K | Buy |
8,021
+411
| +5% | +$33.1K | 0.35% | 54 |
|
|
2017
Q4 | $643K | Hold |
7,610
| – | – | 0.34% | 60 |
|
|
2017
Q3 | $651K | Buy |
7,610
+45
| +0.6% | +$3.69K | 0.37% | 56 |
|
|
2017
Q2 | $623K | Sell |
7,565
-618
| -8% | -$50.4K | 0.36% | 55 |
|
|
2017
Q1 | $688K | Sell |
8,183
-217
| -3% | -$17.4K | 0.41% | 55 |
|
|
2016
Q4 | $618K | Hold |
8,400
| – | – | 0.38% | 58 |
|
|
2016
Q3 | $674K | Hold |
8,400
| – | – | 0.43% | 54 |
|
|
2016
Q2 | $661K | Buy |
8,400
+80
| +1% | +$6.02K | 0.44% | 53 |
|
|
2016
Q1 | $599K | Buy |
8,320
+658
| +9% | +$49.8K | 0.42% | 55 |
|
|
2015
Q4 | $646K | Sell |
7,662
-30
| -0.4% | -$2.49K | 0.44% | 54 |
|
|
2015
Q3 | $644K | Sell |
7,692
-5
| -0.1% | -$422 | 0.47% | 52 |
|
|
2015
Q2 | $643K | Hold |
7,697
| – | – | 0.43% | 53 |
|
|
2015
Q1 | $559K | Buy |
7,697
+35
| +0.5% | +$2.49K | 0.37% | 57 |
|
|
2014
Q4 | $497K | Hold |
7,662
| – | – | 0.37% | 56 |
|
|
2014
Q3 | $497K | Hold |
7,662
| – | – | 0.37% | 56 |
|
|
2014
Q2 | $476K | Buy |
7,662
+65
| +0.9% | +$3.88K | 0.34% | 57 |
|
|
2014
Q1 | $447K | Buy |
7,597
+62
| +0.8% | +$3.46K | 0.35% | 57 |
|
|
2013
Q4 | $384K | Buy |
7,535
+661
| +10% | +$33.1K | 0.31% | 56 |
|
|
2013
Q3 | $346K | Buy |
6,874
+139
| +2% | +$7.28K | 0.3% | 57 |
|
|
2013
Q2 | $331K | Buy |
+6,735
| New | +$366K | 0.31% | 58 |
|
Other funds holding LLY
Garrison Asset Management's LLY Position: Q3 2024 in Review
Garrison Asset Management reduced its Eli Lilly (LLY) stake by 12% in Q3 2024, selling an estimated $271K and leaving 2,276 shares worth $2.02M. The position accounts for 1.02% of the portfolio, ranked #42.
Garrison Asset Management first reported a position in LLY in Q2 2013 and has held it in 46 quarters since. The position peaked at $2.33M in Q2 2024. 3,658 funds tracked by Wall St. Rank hold LLY as of Q3 2024.
- Garrison Asset Management held 2,276 shares of Eli Lilly worth $2.02M as of Q3 2024.
- Garrison Asset Management sold 301 Eli Lilly shares in Q3 2024, an estimated $271K.
- Eli Lilly made up 1.02% of Garrison Asset Management's portfolio in Q3 2024, its #42 holding.
- Garrison Asset Management first reported a position in Eli Lilly in Q2 2013 and has held it in 46 quarters since.
- Garrison Asset Management's Eli Lilly position peaked at $2.33M in Q2 2024.
- 3,658 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2024.
Based on Garrison Asset Management's 13F filing for Q3 2024, filed 30 Oct 2024.